Bob Lutz

Company: Iksuda Therapeutics

Job title: Chief Scientific Officer

Seminars:

Exploring Design Aspects for HER2-targeting ADCs 11:00 am

For full session details, download the full event guideRead more

day: Conference Day One

Panel Discussion: Putting the Pieces Together – Identifying the Characteristics that HER2 Therapeutics Need in Their Design to Enable Them to Achieve Efficacious Results in Breast & Non-Breast Tumors? 4:00 pm

For full session details, download the full event guideRead more

day: Conference Day One